Sumitomo Chemical India Limited – Investor Presentation Summary

Key Operational Highlights

  • FY26 remained a challenging year for the Indian agrochemical industry due to prolonged and excess rainfall during the peak kharif consumption period, delayed rabi demand recovery, biostimulant regulatory challenges, and cautious channel sentiments.
  • Despite industry headwinds, SCIL demonstrated remarkable stability in business performance through disciplined pricing, favourable product mix, and strong execution focus.
  • Herbicides registered strong growth of 87% YoY in Q4FY26 and 19% YoY in FY26, supported by healthy traction in rice herbicide portfolio including Lentigo.
  • Metal Phosphides grew 16% YoY in Q4FY26 and 11% YoY in FY26.
  • Insecticides remained resilient despite weather-related consumption disruptions.
  • Africa exports witnessed strong momentum with 30% YoY growth in Q4FY26 and 26% YoY growth in FY26.
  • Newly launched products including Lentigo, Excalia Max, Powerpull, Advika, Envoy, and Oslava received encouraging market response.
  • Registration of Topgrain was completed during the year, strengthening the future product pipeline.
  • The company maintained strong operational discipline with continued focus on profitability-led growth, receivables management, calibrated inventory control, and disciplined working capital practices.

Key drivers of operational performance: Disciplined pricing, favourable product mix, strong execution focus, and successful new product launches.

Segment-wise Performance

  • Domestic business grew 4% YoY in both Q4FY26 and FY26 despite adverse agro-climatic conditions.
  • Export revenues declined 7% YoY in Q4FY26 and 1% YoY in FY26 due to softer demand and shipment delays in select geographies.

Explanation of significant changes in segment performance: Domestic growth was achieved through disciplined pricing and strong execution despite industry challenges, while export decline was attributed to softer demand in certain international markets.

Financial Highlights

Revenue: Rs. 3,238.3 crore (FY26)

EBITDA: Rs. 670.9 crore (FY26)

PAT: Rs. 543.0 crore (FY26)

EPS: Rs. 10.88 (FY26)

Margins: Gross Profit Margin 42.0% (FY26), EBITDA Margin 20.7% (FY26), Net Profit Margin 16.8% (FY26)

YoY/QoQ comparison: Revenue grew 3% YoY in FY26; PBT before exceptional items increased 11% YoY in Q4FY26 and 9% YoY in FY26; PAT increased 12% YoY in Q4FY26 and 7% YoY in FY26

Drivers of financial performance: Favourable product mix, calibrated pricing actions, disciplined channel management, and lower contribution from low-margin businesses.

Key Risks: Weather conditions, El-Nino related uncertainties, raw material inflation, and geopolitical developments.

Geographical Revenue Split

Domestic vs Export Revenue: Domestic business grew 4% YoY; Export revenues declined 1% YoY for FY26.

Regional Breakdown: Africa exports continued to witness strong momentum with 26% YoY growth in FY26.

Balance Sheet Snapshot

Net Debt/Equity: Essentially debt-free with borrowings of only Rs. 1.5 crore against equity of Rs. 3,393.8 crore.

Reserves: Other Equity of Rs. 2,890.5 crore.

Current Assets/Liabilities: Current Assets Rs. 3,340.2 crore; Current Liabilities Rs. 969.8 crore.

Working Capital/Leverage Metrics: Net Working Capital Rs. 649.9 crore; Working Capital Days 103 days.

Financial Health Insights: Cash, Cash Equivalents & Liquid Investments of ~Rs. 2,113 crore as on 31st March 2026; strong cash flow generation and prudent working capital management.

Capex & Cash Flow Health

Capital Expenditure: New capex announced - ~Rs 150 crore for herbicide intermediate plant at Dahej and ~Rs 10 crore for fitment at Tarapur site.

Free Cash Flow: Not explicitly specified in presentation.

Operating Cash Flow: Net Cash from Operating Activities Rs. 445.5 crore (FY26).

Net Debt Movement: Essentially debt-free position maintained.

Investment Rationale: Developing Dahej as a strategic global manufacturing hub for parent company's high-potential patented molecules; enhancing asset utilization at Tarapur.

Strategic & R&D Initiatives

Investments in Innovation: 3 fully equipped, DSIR approved R&D labs; R&D Team of 75+ qualified professionals; 25+ patents granted across various geographies; 9 applications filed.

Expected impact on growth: Development of new processes and combinations using SCC Japan's chemistries to improve production processes and efficiency.

Strategic Rationale: To be a trusted market leader in Indian crop-protection sector; achieve success and sustainability through innovation & excellence.

Industry Trends & Business Environment

Macro/Industry Trends: Challenging year for Indian agrochemical industry due to weather disruptions, regulatory challenges, and cautious channel sentiments.

Impact on Company: Despite industry headwinds, company demonstrated stability and achieved record profitability through operational discipline.

Management Commentary & Growth Outlook

Strategic Outlook: Management remains cautiously optimistic while remaining watchful of weather conditions, El-Nino related uncertainties, raw material inflation and geopolitical developments.

FY Guidance: The Company continues to focus on demand generation, differentiated product offerings, calibrated pricing actions, operational agility and strengthening of channel partnerships to drive sustainable and profitable growth in FY27.

Market Share Targets: Not explicitly specified.

Risks and Opportunities: Weather conditions, El-Nino uncertainties, raw material inflation, geopolitical developments.

Management Changes

  • Mr. Mukul Govindji Asher's current and final term as Independent Director and Chairman to be till 31st August 2026.
  • Mr. Chetan Shantilal Shah's current and final term as Managing Director to be till 31st August 2026; proposed to be appointed as Non-Executive Non-Independent Director from 1st September 2026.
  • Mr. Sushil Champaklal Marfatia's current and final term as Executive Director to be till 31st August 2026.
  • Mr. N. Sivaraman proposed to be re-appointed as Independent Director from 1st September 2026 till 31st August 2029.
  • Mr. Anand Mohan Tiwari proposed to be appointed as Independent Director from 31st August 2026 up to 30th August 2028.
  • Dr. Suresh Ramachandran proposed to be appointed as Managing Director with effect from 1st September 2026.

Corporate Initiatives

  • 'Every Day Farmers' Day' campaign with 173 innovative activities and more than 7,000 votes cast.
  • Sumi Manthan 2026 annual conference held with theme 'Collaborate to Conquer'.
  • Won GenAI-Led Creative Award at ad:tech India New Delhi for Sumi Max digital campaign.